Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: Proposal of three new species

被引:69
作者
Alvarez, Eduardo [1 ,2 ]
Stchigel, Alberto M. [1 ,2 ]
Cano, Josep [1 ,2 ]
Sutton, Deanna A. [3 ]
Fothergill, Annette W. [3 ]
Chander, Jagdish [4 ]
Salas, Valentina [1 ,2 ]
Rinaldi, Michael G. [3 ]
Guarro, Josep [1 ,2 ]
机构
[1] Univ Rovira & Virgili, Mycol Unit, Sch Med, E-43201 Reus, Spain
[2] Univ Rovira & Virgili, IISPV, E-43201 Reus, Spain
[3] Univ Texas Hlth Sci Ctr San Antonio, Fungus Testing Lab, San Antonio, TX 78229 USA
[4] Govt Med Coll & Hosp, Chandigarh, India
来源
REVISTA IBEROAMERICANA DE MICOLOGIA | 2010年 / 27卷 / 02期
关键词
Apophysomyces elegans; Apophysomyces ossiformis; Apophysomyces trapeziformis; Apophysomyces variabilis; Phylogeny; Taxonomy; Zygomycetes; IN-VITRO SUSCEPTIBILITIES; ANTIFUNGAL AGENTS; TSUNAMI SURVIVOR; ELEGANS; MUCORMYCOSIS; ZYGOMYCOSIS; POSACONAZOLE;
D O I
10.1016/j.riam.2010.01.006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Apophysomyces is a monotypic genus belonging to the order Mucorales. The species Apophysomyces elegans has been reported to cause severe infections in immunocompromised and immunocompetent people. In a previous study of Alvarez et al.(3) [J Clin Microbiol 2009;47:1650-6], we demonstrated a high variability among the 5.8S rRNA gene sequences of clinical strains of A. elegans. Material and methods: We performed a polyphasic study based on the analysis of the sequences of the histone 3 gene, the internal transcribed spacer region of the rDNA gene, and domains D1 and D2 of the 28S rRNA gene, as well as by evaluation of some relevant morphological and physiological characteristics of a set of clinical and environmental strains of A. elegans. Results and conclusions: We have demonstrated that A. elegans is a complex of species. We propose as new species Apophysmyces ossiformis, characterised by bone-shaped sporangiospores, Apophysomyces trapeziformis, with trapezoid-shaped sporangiospores, and Apophysomyces variabilis, with variable-shaped sporangiospores. These species failed to assimilate esculin, whereas A. elegans was able to assimilate that glycoside. Amphotericin B and posaconazole are the most active in vitro drugs against Apophysomyces. (C) 2009 Revista Iberoamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 27 条
  • [1] Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers
    Alastruey-Izquierdo, Ana
    Victoria Castelli, Maria
    Cuesta, Isabel
    Monzon, Araceli
    Cuenca-Estrella, Manuel
    Luis Rodriguez-Tudela, Juan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1686 - 1689
  • [2] In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents
    Almyroudis, Nikolaos G.
    Sutton, Deanna A.
    Fothergill, Annette W.
    Rinaldi, Michael G.
    Kusne, Shimon
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2587 - 2590
  • [3] Spectrum of Zygomycete Species Identified in Clinically Significant Specimens in the United States
    Alvarez, E.
    Sutton, D. A.
    Cano, J.
    Fothergill, A. W.
    Stchigel, A.
    Rinaldi, M. G.
    Guarro, J.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (06) : 1650 - 1656
  • [4] Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka
    Andresen, D
    Donaldson, A
    Choo, L
    Knox, A
    Klaassen, M
    Ursic, C
    Vonthethoff, L
    Krilis, S
    Konecny, P
    [J]. LANCET, 2005, 365 (9462) : 876 - 878
  • [5] Apophysomyces elegans:: an emerging zygomycete in India
    Chakrabarti, A
    Ghosh, A
    Prasad, GS
    David, JK
    Gupta, S
    Das, A
    Sakhuja, V
    Panda, NK
    Singh, SK
    Das, S
    Chakrabarti, T
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) : 783 - 788
  • [6] BURN WOUND ZYGOMYCOSIS CAUSED BY APOPHYSOMYCES-ELEGANS
    COOTER, RD
    LIM, IS
    ELLIS, DH
    LEITCH, IOW
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2151 - 2153
  • [7] In vitro susceptibilities of zygomycetes to conventional and new antifungals
    Dannaoui, E
    Meletiadis, J
    Mouton, JW
    Meis, JFGM
    Verweij, PE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 45 - 52
  • [8] de Hoog G.S., 2000, ATLAS CLIN FUNGI
  • [9] DEHOOG GS, 1994, MYCOSES, V37, P71, DOI 10.1111/j.1439-0507.1994.tb00780.x
  • [10] DEVELOPMENT OF PRIMER SETS DESIGNED FOR USE WITH THE PCR TO AMPLIFY CONSERVED GENES FROM FILAMENTOUS ASCOMYCETES
    GLASS, NL
    DONALDSON, GC
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1995, 61 (04) : 1323 - 1330